Robert Chen is a wetlab scientist in team Immunology focused on building Cartography’s scientific operations and advancing our CAR-T proof of concept assets. Some projects he has played a role in have been: streamlining our validation strategy for new targets, outfitting our Chess Drive facility, and pushing custom binders through our synthetic biology pipeline to functional readouts. Prior to starting at Cartography, Robert created novel circular RNA therapeutics during his PhD at Stanford. In his free time, he enjoys elaborate cooking and fermentation projects, long runs in the Santa Cruz Mountains, and organizing camping treks.
Recent Posts
- Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
- Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
- Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
- Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
- Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
Recent Comments
No comments to show.